tiprankstipranks
Trending News
More News >
Race Oncology Ltd. (AU:RAC)
ASX:RAC
Australian Market

Race Oncology Ltd. (RAC) Price & Analysis

Compare
21 Followers

RAC Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.27%99.73%
Mutual Funds
― Other Institutional Investors
99.73% Public Companies and
Individual Investors

RAC FAQ

What was Race Oncology Ltd.’s price range in the past 12 months?
Race Oncology Ltd. lowest share price was AU$0.92 and its highest was AU$2.09 in the past 12 months.
    What is Race Oncology Ltd.’s market cap?
    Race Oncology Ltd.’s market cap is AU$204.14M.
      When is Race Oncology Ltd.’s upcoming earnings report date?
      Race Oncology Ltd.’s upcoming earnings report date is Aug 22, 2025 which is in 77 days.
        How were Race Oncology Ltd.’s earnings last quarter?
        Race Oncology Ltd. released its earnings results on Feb 25, 2025. The company reported AU$0.003 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.003.
          Is Race Oncology Ltd. overvalued?
          According to Wall Street analysts Race Oncology Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Race Oncology Ltd. pay dividends?
            Race Oncology Ltd. does not currently pay dividends.
            What is Race Oncology Ltd.’s EPS estimate?
            Race Oncology Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Race Oncology Ltd. have?
            Race Oncology Ltd. has 173,733,550 shares outstanding.
              What happened to Race Oncology Ltd.’s price movement after its last earnings report?
              Race Oncology Ltd. reported an EPS of AU$0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Race Oncology Ltd.?
                Currently, no hedge funds are holding shares in AU:RAC

                Race Oncology Ltd. Stock Smart Score

                Company Description

                Race Oncology Ltd.

                Race Oncology Ltd. (RAC) is an Australian pharmaceutical company focused on the development and commercialization of oncology therapies. The company is engaged in the research and development of innovative cancer treatments, with a particular emphasis on the use of its flagship drug, bisantrene, for the treatment of various cancer types. Race Oncology operates within the biotechnology and pharmaceutical sectors, aiming to provide effective solutions to unmet medical needs in oncology.
                Similar Stocks
                Company
                Price & Change
                Follow
                Opthea
                Telix Pharmaceuticals
                Prescient Therapeutics Limited
                Biotron
                Imugene Limited
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis